This project presents one application direction of the IARIP research architecture. The presented model is currently in the research and pilot validation phase. The timelines below outline the expected validation and development steps of the IARIP research architecture across different application domains. Following research validation, IARIP aims to initiate real-world projects together with industry and market partners based on the successfully validated models.

A nationwide, data-driven framework for health monitoring and preventive strategy

Program Vision and Core Objective

The National Resonant Health Data and Prevention Program aims to establish a nationwide health monitoring and prevention infrastructure capable of detecting and interpreting early physiological deviations through non-invasive, trend-based analysis.

The program does not focus on disease treatment, but on prevention, early signal detection, and long-term quality of life improvement. Health is approached as a dynamic state, not as a static clinical diagnosis.

Individual measurements are transformed into fully anonymized, aggregated health patterns, enabling:

• – evidence-based public health decision-making,
• – targeted prevention programs,
• – and long-term reduction of healthcare system burden.

Program Logic and Structure

The program integrates three interconnected levels:

1. Individual Level – Awareness and Self-Monitoring

• – biosensor-based and digital measurement tools
• – tracking trends relative to personal baseline states
• – feedback focused on condition awareness, not diagnosis

2. Institutional Level – Prevention and Planning

• – analysis of anonymized, aggregated datasets
• – identification of regional and demographic health patterns
• – design of targeted prevention initiatives

3. National Level – Health Policy and Sustainability

• – data-informed national health strategies
• – long-term cost reduction through prevention
• – support for a healthier, more active population

Technological and Operational Components

Health Data Collection (Non-Clinical):

• – biosensor-derived indicators (stress, inflammation, metabolic load proxies)
• – time-series tracking of physiological trends
• – voluntary participation based on informed consent

Data Interpretation and Decision Support:

• – bioinformatic and statistical pattern analysis
• – identification of regional, lifestyle, and environmental correlations
• – structured, interpretable reports for policymakers

Data Security and Ethics:

• – full anonymization and aggregation
• – no individual-level data accessed at institutional or governmental level
• – transparent, ethically governed data management framework

Program Phases (2–6 Years)

Phase 1 – Preparation and Pilot (Years 1–2)

• – limited regional or institutional pilot deployment
• – validation of data collection and analysis models
• – collection of institutional and public feedback

Phase 2 – Regional Expansion (Years 3–4)

• – extension to multiple regions
• – creation of comparable health pattern datasets
• – launch of targeted regional prevention programs

Phase 3 – National Operation (Years 5–6)

• – stable nationwide health monitoring infrastructure
• – regular national health trend reports
• – continuous decision support for health policy planning

Institutional Stakeholders

• – public health authorities and agencies
• – ministries of health and affiliated institutions
• – insurance and prevention-focused organizations
• – universities and research institutes
• – digital government and smart-state programs

Expected Social and Economic Impact

• – reduced long-term healthcare system load
• – earlier identification of chronic risk trajectories
• – more effective and targeted prevention programs
• – sustained healthcare cost savings
• – increased public health awareness and engagement

Alignment with the AVA Development Framework

Within this program, AVA does not act as a healthcare authority or decision-maker, but as:

• – an analytical and pattern-recognition intelligence layer,
• – supporting the interpretation of complex health data trends,
• – enabling evidence-based prevention strategy design.

The National Resonant Health Data and Prevention Program thus serves as a robust mid-term bridge between pilot Bio–Nano initiatives and future large-scale, integrated health ecosystem models.